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BACKGROUND: Hypoxia is an element of the tumour microenvironment that impacts upon numerous cellular factors linked to clinical
aggressiveness in cancer. One such factor, Snail, a master regulator of the epithelial–mesenchymal transition (EMT), has been
implicated in key tumour biological processes such as invasion and metastasis. In this study we set out to investigate regulation of EMT
in hypoxia, and the importance of Snail in cell migration and clinical outcome in breast cancer.
METHODS: Four breast cancer cell lines were exposed to 0.1% oxygen and expression of EMT markers was monitored. The migratory
ability was analysed following Snail overexpression and silencing. Snail expression was assessed in 500 tumour samples from
premenopausal breast cancer patients, randomised to either 2 years of tamoxifen or no adjuvant treatment.
RESULTS: Exposure to 0.1% oxygen resulted in elevated levels of Snail protein, along with changes in vimentin and E-cadherin
expression, and in addition increased migration of MDA-MB-468 cells. Overexpression of Snail increased the motility of MCF-7,
T-47D and MDA-MB-231 cells, whereas silencing of the protein resulted in decreased migratory propensity of MCF-7, MDA-MB-468
and MDA-MB-231 cells. Moreover, nuclear Snail expression was associated with tumours of higher grade and proliferation rate, but
not with disease recurrence. Interestingly, Snail negativity was associated with impaired tamoxifen response (P¼0.048).
CONCLUSIONS: Our results demonstrate that hypoxia induces Snail expression but generally not a migratory phenotype, suggesting
that hypoxic cells are only partially pushed towards EMT. Furthermore, our study supports the link between Snail and clinically
relevant features and treatment response.
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Epithelial–mesenchymal transition (EMT) is a biological process
defining progression from a polarised epithelial phenotype to a
mesenchymal phenotype, which is distinguished by fibroblast-like
features (Thiery and Sleeman, 2006). Epithelial–mesenchymal
transition is characterised by a change in the cell-type-specific
protein repertoire and facilitation of cell motility, is essential for
generation of new tissue types during embryogenesis, and has a
pivotal role in inflammation and wound healing of adult tissue
(Thiery, 2003; Flint et al, 2008). In addition, it has been implicated
in the fundamental steps of tumorigenesis such as invasion and
metastasis (Sleeman, 2000). Epithelial–mesenchymal transition is
considered a transient and reversible process and represents only
one of several steps required for tumour progression via invasion
and metastatic spread (Christiansen and Rajasekaran, 2006). As
reviewed by Christiansen et al there are several reports describing
a partial or incomplete EMT phenotype of advanced carcinomas,
displaying some mesenchymal features, but with a retention of
well-differentiated epithelial-cell characteristics (Christiansen and
Rajasekaran, 2006).
The architectural arrangement of an epithelial tissue is
characterised by an intricate network of junctional structures such
as tight, gap and adherens junctions and desmosomes. Cadherins
are important for stabilisation of these structures, and in particular
E-cadherin (Matter and Balda, 2003). An important hallmark of
EMT is loss of E-cadherin expression, resulting in destabilisation
of the cell–cell contacts and detachment of cells from its
surroundings. This crucial event results from repression of the
E-cadherin gene transcription via overexpression of several
different EMT-inducing repressors, such as the zinc-finger
transcription factors Slug (Hajra et al, 2002) and the focus of
our study; Snail (Barrallo-Gimeno and Nieto, 2005).
Overexpression of Snail has been reported to be a sufficient
inducer of EMT as well as being predictor for an aggressive tumour
phenotype (Cano et al, 2000). In breast cancer increased Snail
expression has been associated with lymph node involvement,
invasiveness and metastatic potential (Cheng et al, 2001; Blanco
et al, 2002), and also with decreased recurrence-free survival
(Moody et al, 2005). Kurrey et al (2005) reported ectopic Snail or
Slug expression to result in induction of EMT in an ovarian
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scarcinoma cell line, with enhanced motility and invasiveness, loss
of expression of epithelial markers and increased expression of
vimentin. Stable silencing of endogenous Snail concomitantly
induced complete mesenchymal–epithelial transition in MDCK-
Snail cells, and reduction of in vivo tumour growth of two
independent, stably Snail-silenced carcinoma cell lines (Olmeda
et al, 2007).
Besides the importance of the tumour cell itself, it is well
established that the tumour microenvironment also plays a crucial
role in carcinogenesis (Liotta and Kohn, 2001). Hypoxia is a common
feature of solid tumours and affects several important biological
processes, and is also linked to clinical aggressiveness (Harris, 2002).
Hypoxia is predominantly caused by abnormal vasculature formation
of the rapidly growing tumour mass, and the net result is
heterogeneously distributed areas of low oxygen pressure (Vaupel
et al, 2002). Tumour cell adaptation allows survival and gives rise to
heterogeneity and selection of resistant clones, consequently resulting
in a more malignant phenotype (Semenza, 2003). The hypoxic
response mediated by the transcription factor hypoxia-inducible
factor-1 (HIF-1) activates target genes involved in a number of
different cellular processes, such as proliferation, angiogenesis and
EMT, all linked to malignant progression (Semenza, 2002; Imai et al,
2003; Yang and Wu, 2008). Upregulation of Snail mRNA expression
under hypoxic conditions, accompanied by downregulation of E-
cadherin, has been reported in ovarian cancer cell lines (Imai et al,
2003; Kurrey et al, 2005), and invasiveness of hypoxic ovarian cancer
cell lines has also been shown to increase (Imai et al, 2003).
Furthermore, Lester et al (2007) reported that exposure of the human
breast cancer cell line MDA-MB-468 to 1% oxygen resulted in
increased vimentin expression, decreased E-cadherin levels and
nuclear translocation of the Snail protein. Notably, these cells adopted
a mesenchymal-like morphology, increased their migratory capacity
a n dw e r ea b l et od i s s e m i n a t ein vivo.
Becker et al (2007) published a summary of 21 studies, where 10
were conducted using breast carcinomas, describing the expression
of Snail with regard to clinicopathological parameters and disease
outcome in a large number of samples from several different cancers.
This report points out the discrepancy between studies and the use of
different Snail antibodies, and emphasises that selection of novel
Snail-specific antibodies may facilitate the establishment of a
potential clinical importance for this EMT regulator.
In this study we, thus, focused on elucidating the regulation of
EMT via Snail induction, and on the relationship between EMT
and hypoxia, in a panel of breast cancer cell lines, using a well
validated Snail-specific antibody. Furthermore, the importance of
Snail expression in primary breast cancer was examined in a
clinical material consisting of 500 invasive premenopausal breast
cancer cases, and in full sections of ductal carcinoma in situ
(DCIS). We show that Snail protein expression increased in breast
cancer cell lines exposed to severe hypoxia (0.1%) and that
expression of E-cadherin and the mesenchymal marker vimentin
were also affected in some cell lines. Nuclear localisation of the
protein further seemed to be linked to the EMT-inducing function
of Snail. Cell motility increased in one cell line only, following
exposure to hypoxia, which turned out to be independent of Snail.
Moreover, we demonstrate that Snail expression is important for
migration of breast cancer cell lines, through overexpression and
silencing of the protein. Finally, nuclear expression of Snail was
shown to be associated with higher grade and high proliferation
rate in primary breast cancer. In addition, we for the first time
show that Snail is a predictor for tamoxifen response.
MATERIALS AND METHODS
Cell lines, Western blot and immunocytochemistry
For this study we used the human breast cancer cell lines MCF-7, T-
47D, MDA-MB-468 and MDA-MB-231 (ATCC, Manassas, VA, USA).
MCF-7 cells were grown in Improved MEM zinc option supple-
mented with 5% fetal bovine serum (FBS) and 1% penicillin/
streptomycin (PEST), T-47D in DMEM supplemented with 10% FBS
and 1% PEST and MDA-MB-468 and MDA-MB-231 in RPMI 1640
supplemented with 10% FBS, 1mM sodium pyruvate and 1% PEST.
Cell lysates and pellets were made from the cell lines exposed to
0.1% O2 for increasing time points from 2 to 96h, where time point
zero defined normoxia (21% O2). Cells were seeded to avoid
confluence at the time for harvest. For immunocytochemistry (ICC)
cells were harvested by trypsinisation, washed in PBS, fixed in 4%
paraformaldehyde for 25min, stained with Meyer’s haematoxylin
for 5min and centrifuged at 1500 r.p.m. for 5min with the
subsequent pellet resuspended in ice-cold 70% ethanol. Pellets were
dehydrated in graded ethanol series, embedded in paraffin and a
cell-line array was constructed and stained with antibodies,
according to staining procedures described below. For the ICC
staining of HIF-1a t h en u m b e ro fH I F - 1 a-positive cells was counted
in three equal fields for each time point and cell line, with an
average calculated for each time point.
For Western blot analysis cells were trypsinised, centrifuged,
washed and pellets were stored at  801C for 1h. Cells were then
lysed in buffer containing 0.5% NP-40, 0.5% NaDOC, 0.1% SDS,
50mM TRIS (pH 7.0), 150mM NaCl, 1mM EDTA (pH 8.0), 1mM
NaF, 0.1mg/ml PMSF and a Complete Mini protease inhibitor
cocktail tablet (Roche, Mannheim, Germany). Cell extracts were
incubated on ice for 30min, with vortexing every 10min, and
centrifuged at 14000 r.p.m for 30min. Supernatants were collected
and protein concentrations were measured with a BCA Protein
Assay kit (Pierce, Rockford, IL, USA). For each protein sample 10mg
was resolved on SDS–polyacrylamide gels and then transferred to
Hybond ECL nitrocellulose membranes (Amersham Pharmacia
Biotech, Buckinghamshire, UK). Membranes were incubated with
rat monoclonal anti-human Snail (1:400, clone SN9H2; Cell
Signaling Technology, Beverly, MA, USA), mouse monoclonal
anti-human E-cadherin (1:500, clone 4A2C7; Zymed Laboratories,
Invitrogen immunodetection, San Francisco, CA, USA), mouse
monoclonal anti-human vimentin (1:250, clone V9; Dako, Glostrup,
Denmark) antibody and polyclonal goat anti-human b-actin anti-
body (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for
2h followed by incubation with secondary horseradish peroxidase-
conjugated anti-rat or mouse (Amersham Life Science, Alesbury,
UK) and anti-goat antibodies (Sigma, Gothenburg, Sweden) for 1h.
Membrane-bound antibody was detected by using the ECL
þ system
(Amersham Life Science, Alesbury, UK).
Transfections
For transient expression of wild-type Snail we used the HA-Snail-
246A plasmid (Yang et al, 2005) provided by Dr Kumar (MD
Andersen Cancer Center, Houston). For transfections of MCF-7
and T-47D in six-well plates the Amaxa Nucleofector kit V was
used according to the manufacturer’s protocol (Amaxa Inc.,
Gaithersburg, MD, USA). A 2-mg weight of DNA was added per
well of a six-well plate. MDA-MB-468 and MDA-MB-231 were
transiently transfected with Snail vector using Lipofectamine 2000
according to the manufacturer’s recommendations (Invitrogen Life
Technologies, Carlsbad, CA, USA). A 2-mg weight of DNA was used
per well of a six-well plate. For Snail knockdown MDA-MB-468
and MDA-MB-231 cells were transfected with 50nM control siRNA
or siRNA against Snail (ON-TARGET plus siRNA SMARTpool;
Dharmacon, Lafayette, CO, USA) using Dharmafect (Dharmacon,
Lafayette, CO, USA). Cells were allowed to grow 24 or 48h after
transfection before harvesting for migration assay.
Migration assay
Migration assays were performed using Transwell migration
chambers with 8mm pore membranes (Corning Inc., Corning,
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sNY, USA). Cells (10
5) were resuspended in upper Transwell
chambers in serum-free media and allowed to migrate towards a
serum gradient (10%) in the lower chamber for 3h (MDA-MB-231)
or 6h (MCF-7, T-47D and MDA-MB-468). Membranes were then
excised and cells on the upper side were removed before fixing in
4% paraformaldehyde and staining with DAPI (406-diamidino-2-
phenylindole), prior to mounting. The number of migrating cells
was counted in three randomly chosen fields on each membrane
and photographed at  10 magnification. Values reported are the
averages of three experiments performed in triplicates.
Patient material
Patient cohort Between 1986 and 1991, 564 premenopausal breast
cancer patients with invasive stage-II disease were enrolled in a
Swedish trial (SBII:2a) where they were randomly assigned to 2
years of adjuvant tamoxifen (n¼276) or no adjuvant treatment
(control, n¼288). The aim of the original study was examine the
effect of tamoxifen treatment (20 or 40mg daily) on recurrence-
free survival. Patients were included irrespective of hormone
receptor status. All patients were followed up for recurrence-free
and overall survival. Recurrence was defined as local, regional or
distant recurrence, and breast cancer-specific death. A new
contralateral breast cancer was not recorded as recurrence, but
was separately analysed. Surgery was modified radical mastectomy
or breast conserving surgery, followed by radiotherapy, and in few
cases adjuvant polychemotherapy (less than 2%). The median
post-surgery follow-up time without breast cancer event was 13.9
years. Detailed description of the SBII:2a study can be further
obtained from a previous report (Ryden et al, 2005). Informed
consent was obtained from the patients participating in the
randomised study and the ethical committees at Lund and
Linko ¨ping Universities approved the study and the reanalysis of
the tumour material.
Ductal carcinoma in situ
Twenty-five full sections taken from patients with DCIS were
chosen from archived formalin-fixed, paraffin-embedded surgical
breast tumour specimens at Department of Pathology, Malmo ¨
University Hospital. Inclusion criteria were symmetrical DCIS
lesions with central necrosis.
Tissue specimens and immunohistochemistry
Formalin-fixed, paraffin-embedded tumour material was available
from 500 of the 564 patients in the trial. Areas representative of
invasive cancer were selected and assembled in a tissue microarray
(TMA). Two 0.6-mm tissue cores from each donor block were
placed in recipient paraffin blocks using an automated tissue
arrayer (Beecher Instruments Microarray Technology, Woodland,
MD, USA). Sections (4mm) from this block were mounted on slides
before they were deparaffinised, rehydrated and microwave-
treated in target retrieval solution at pH 9.9 (Dako, Glostrup,
Denmark), before being processed with an automated immuno-
stainer (Techmate 500; Dako, Copenhagen, Denmark), using the
Envision software (Dako, Glostrup, Denmark). The antibody
employed was Snail (1:100). Staining was evaluated by two
independent observers (one pathologist), to obtain a result as
correct and representative as possible. Conflicting observations
were low (o5%) for all evaluations made. All immunohistochem-
ical (IHC) evaluations were performed without knowledge of
tumour characteristics. In cases of no evaluation, cores were either
non-representative (i.e., contained no invasive tumour cells) or
missing. Data for expression of the oestrogen receptor-a (ERa) and
the progesterone receptor (PR) were available from a previous
study (Ryden et al, 2005). Expression of the proliferation marker
Ki67 had also been evaluated in a previous study (Jirstrom et al,
2005). Carbonic anhydrase-IX (CAIX) staining (Brennan et al,
2006) as well as HIF-1a staining (Kronblad et al, 2006) had also
previously been evaluated. Formalin-fixed, paraffin-embedded
full section DCIS and arrays of cell pellets were treated as
previously described. Antibodies employed were Snail (1:100),
E-cadherin (1:100), vimentin (1:1000) and mouse monoclonal
anti-human HIF-1a (1:100, clone 54; BD Biosciences, Erembodegem,
Belgium).
ICC evaluation of cytoplasmic and nuclear Snail expression
SlidePath’s Positive Pixels Algorithm (Digital Slide Server) was
used for evaluation of ICC staining of cytoplasmic Snail protein in
the different cell lines. The algorithm detects positively stained
pixels within the image. The analysis was performed on three
randomly chosen fields for each time point and cell line, on the
array made from cell pellets, and an average was calculated. For
more detailed description we refer to the Tissue Image Analysis
User Guide (SlidePath Ltd., Dublin, Ireland). For the ICC staining
of nuclear Snail the percentage positive nuclei was manually
counted in three equal fields for each time point and cell line, with
an average calculated for each time point.
Statistical methods
Statistical analyses were performed using the SPSS software
(version 15.0; SPSS, Chicago, IL, USA). The Wilcoxon/Mann–
Whitney test and Fisher’s exact test were used for associations
between Snail expression and clinicopathological parameters and
tumour markers. To study recurrence-free survival the Kaplan–
Meier method was used, and the log-rank test was applied for
comparison of recurrence-free survival among different treatment
groups. A Cox proportional-hazards regression model was used for
the estimation of relative risk in multivariate analysis. All P-values
corresponded to two-sided tests and a P-value less than 0.05 was
considered statistically significant.
RESULTS
Snail is expressed in breast cancer cell lines
Prior to this study we had been evaluating a number of different
Snail antibodies and found that some were unspecific and reacted
also with the closely related family member Slug. The reactivity of
the Snail-specific antibody used in our study was further validated
through comparison of the expression pattern by Western blot and
immunocytochemical analysis of protein lysates and pellets made
from the human breast cancer cell lines MCF-7, T-47D, MDA-MB-
468 and MDA-MB-231. Both methods revealed a similar expression
pattern for the protein in the cell lines (data not shown). Staining
was both nuclear and cytoplasmic, as observed by ICC. In Western
blot a band corresponding to the predicted molecular weight for
Snail was obtained at 29kDa (Supplementary Figure 1). Bands
corresponding to the EMT markers E-cadherin and vimentin
were obtained at B100 and 54kDa, respectively (Supplementary
Figure 1).
Hypoxia induces an EMT phenotype in breast cancer cell
lines
First, the effect of hypoxia on EMT regulation was studied in the
four cell lines. Cells were exposed to 0.1% oxygen from 2 to 96h.
Expression of HIF-1a was used to visualise the hypoxic response,
and the expression pattern differed between the four cell lines.
Expression of HIF-1a peaked between 4 and 8h in all cell lines,
and then declined (Figure 1A). For MCF-7, and MDA-MB-231
a less prominent expression peak was observed at 48 and 24h
respectively. Interestingly, exposure to 0.1% oxygen increased
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sthe protein levels of Snail in all cell lines. Snail expression
increased over time, but with a slightly different expression
pattern among cell lines, as demonstrated by Western blot
(Figure 1B). Similar observations were made on ICC stainings of
cell pellets, as shown for T-47D and MDA-MB-231 (Figure 1C).
Cytoplasmic intensity as well as number of cells exhibiting
nuclear Snail expression increased over time. E-cadherin protein
expression, which was present in all cell lines except for MDA-MB-
231, decreased only in MCF-7 cells, starting at approximately
4h, and after 72h the expression was significantly reduced (Figure
1B and C). Expression of the mesenchymal marker vimentin,
which is expressed only by MDA-MB-231 cells at normoxia,
increased during exposure of MDA-MB-468 and MDA-MB-231 to
hypoxia, more easily detectable by ICC (Figure 1B and C).
Proliferation, as measured by Ki67, was maintained at a high level
throughout the time course of hypoxic exposure (Supplementary
Figure 2). Since EMT is associated with tumour invasiveness and
metastasis, we wanted to confirm that EMT-induced cells are
motile. Interestingly, we found that the migratory capacity of
MDA-MB-468 cells exposed to hypoxia for 48h increased
three-fold relative to normoxic cells (Figure 1D). However,
migration was not affected in MCF-7 and T-47D cells, and in
contrast, MDA-MB-231 cells exhibited significantly lower migra-
tory ability when exposed to hypoxia (Figure 1D). Taken together,
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Figure 1 EMT marker expression and migratory capacity in breast cancer cell lines exposed to hypoxia. (A) HIF-1a expression representing the hypoxic
response peaked between 4 and 8h in all cell lines, and again at 48h but with a lower expression level in MCF-7 cells, and at 24h in MDA-MB-231 cells. (B)
Snail expression increased in all the cell lines, with a slight variation in expression levels over time. E-cadherin protein levels decreased in MCF-7 cells starting
at 4h and was significantly reduced after 72h, and fluctuated over time in MDA-MB-468 cells. A slight increase of vimentin expression was detected in
Western blot in MDA-MB-468 and MDA-MB-231 cells. (C) Vimentin expression detected by ICC increased in MDA-MB-468 and MDA-MB-231 cells upon
hypoxic exposure, and was markedly upregulated at 96h in both cell lines. The ICC confirms downregulation of E-cadherin in MCF-7 cells and increased
levels of both cytoplasmic and nuclear Snail is exemplified for T-47D and MDA-MB-231 cells. (D) The migratory ability of MDA-MB-468 cells increased
three-fold (*Po0.001) vs control when cells were exposed to 0.1% oxygen for 48h, whereas significantly decreased in hypoxic MDA-MB-231 cells
(
dPo0.001) vs control. The result in panel D is presented as means of three experiments.
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sexposure of these breast cancer cell lines to hypoxia induced
partial EMT that affected the migratory ability in one of the four
cell lines (Table 1).
Subcellular localisation of Snail is affected by hypoxia
Our next objective was to analyse the subcellular localisation of
Snail as an effect of hypoxic exposure. Cytoplasmic staining
intensity, measured by the Positive Pixels Algorithm (developed by
SlidePath Ltd., Dublin, Ireland), increased over time. In all four cell
lines the expression levels peaked between 2 and 8h, and then
again between 72 and 96h (Figure 2A). The lowest expression of
cytoplasmic Snail was observed in MDA-MB-468 cells. In contrast
to the cytoplasmic expression, nuclear expression started to
increase later during hypoxic exposure and peaked at 96h in all
cell lines except for in T-47D. Nuclear expression in T-47D was
retained at a quite low level throughout the time course of
exposure (Figure 2A). Interestingly, the elevated levels of nuclear
Snail detected at later time points corresponded to those in time
Table 1 Expression of EMT markers and migratory potential of breast
cancer cell lines exposed to 0.1% oxygen
E-cadherin Snail Vimentin Migration
MCF-7 .m — ’
T-47D ’ m — ’
MDA-MB-468 ’ mm m
MDA-MB-231 — mm .
Abbreviations: EMT¼epithelial–mesenchymal transition. —, no expression; ’,n o
change; ., downregulation; m, upregulation.
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Figure 2 Subcellular localisation of Snail in breast cancer cells exposed to hypoxia. (A) In MCF-7 cells hypoxia induced cytoplasmic Snail expression with a
peak at 8h, followed by a decline at 12h and again an increased expression. Nuclear expression was increasing over time and peaked at 96h. Expression of
Snail in T-47D fluctuated over time, with a cytoplasmic expression peak at 8h, but no prominent expression peak in the nuclear expression was observed.
Cytoplasmic Snail expression fluctuated over time in MDA-MB-468, with somewhat lower levels between 8 and 72h, whereas nuclear expression peaked at
96h. In MDA-MB-231 cells cytoplasmic as well as nuclear expression showed a prominent peak at 96h. (B) When adding expression levels of all cell lines,
two different expression peaks were observed for cytoplasmic expression, the first one at 8h and the second at 96h. Nuclear Snail expression reached its
highest levels at 96h, when presented for all the cell lines.
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spoints when prominent changes in E-cadherin in MCF-7 cells, and
vimentin expression in MDA-MB-468 and MDA-231 were ob-
served. Adding the expression levels of all the cell lines, two
expression peaks for cytoplasmic expression were observed, one at
8h and the second at 96h (Figure 2B). Since nuclear expression
peaked at 96h in all cell lines except for T-47D, one prominent
peak was detected at 96h when adding the expression of all the cell
lines (Figure 2B).
Overexpression and silencing of Snail impacts upon breast
cancer cell migration
In order to further investigate the role of Snail in cell motility, we
transiently overexpressed and silenced the protein in the cell lines
(Figure 3A). With the exception of MDA-MB-468 cells, the
moderate increase in Snail expression following hypoxic exposure
did not increase the migratory capacity of the cell lines. Hence, we
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Figure 3 Effect of transient overexpression and silencing of Snail on the migratory ability of breast cancer cell lines. (A) Western blots confirming
overexpression and knockdown of Snail and expression of E-cadherin and vimentin for the four cell lines. In MCF-7 cells transfected with Snail vector ad e c r e a s e
in E-cadherin protein levels was observed, and a slight increase in E-cadherin expression could be detected when Snail was silenced. Absence of bands in the
control lanes for overexpression was due to short exposure times. In MDA-MB-468 cells exposed to hypoxia, vimentin expression decreased following Snail
knockdown. (B) Snail overexpression increased migration of MCF-7 and T-47D cells 24h (*, MCF-7: P¼0.034; T-47D: P¼0.025) and 48h (d,M C F - 7 :
P¼0.002; T-47D: P¼0.043) post transfection. (C) The migratory ability of Snail-overexpressing cells increased also in MDA-MB-231 cells (*Po0.001) vs
control 48h post transfection, whereas no change was observed in MDA-MB-468 cells. (D) Knockdown of Snail resulted in decreased migration of MCF-7 cells
(*Po0.001) vs control, but no effect was observed in T-47D cells (E) Snail silencing in MDA-MB-468 and MDA-MB-231 decreased the migratory ability vs
control 48h post transfection (*Po0.001,
dPo0.001). (F) Snail knockdown in MDA-MB-468 cells exposed to hypoxia did not exhibit the decreased migratory
propensity observed for normoxic cells treated with siRNA against Snail. There was a significant difference in migration between normoxic and hypoxic cells
(*P¼0.028), and between normoxic control-transfected and Snail-transfected cells (
dP¼0.023). The results are presented as means of three experiments.
Wide error bars for MCF-7 and T-47D cell migrations are due to low and varying cell number between experiments.
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swanted to elucidate the effect of a prominent increase in Snail
expression on migration. The migratory capacity of the epithelial-
like cell lines MCF-7 and T-47D is low, MDA-MB-468 moderate,
and the mesenchymal-like MDA-MB-231 is highly migratory
(Supplementary Figure 3). Overexpression of Snail in MCF-7 and
T-47D cells resulted in significant increase in cell motility, 24 and
48h post transfection, relative to the control (Figure 3B). Notably,
migration of T-47D was effected even though E-cadherin was not
downregulated as a result of elevated Snail levels (Figure 3A).
Furthermore, Snail overexpression resulted in increased migration
of MDA-MB-231 cells, whereas no effect on MDA-MB-468 cell
migration was observed (Figure 3C). No significant changes in the
expression of either E-cadherin or vimentin were found when Snail
was overexpressed in these two cell lines (Figure 3A). To exclude
the possibility that increased migration following overexpression
of Snail was just an artefact of the actual overexpression, we, in
addition, overexpressed the closely related E-cadherin repressor
Slug in the cell lines. This however, did not result in enhanced
migratory capacity in any of the cell lines (data not shown).
Moreover, silencing of Snail expression in MCF-7, MDA-MB-468
and MDA-MB-231 decreased cell migration significantly, whereas
no effect of the knockdown was observed in T-47D cells (Figure 3D
MCF-7 T-47D
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sand E). Notably, E-cadherin and vimentin levels were unaffected
when Snail was knocked down, except for a slightly elevated
E-cadherin level in MCF-7 cells (Figure 3A).
We further wanted to delineate the link between hypoxia
induced Snail expression and migration in MDA-MB-468 cells,
since the migratory capacity of this only cell line increased as a
result of exposure to hypoxia. Snail was silenced by siRNA and
cells were grown for 48h in either normoxia (21% oxygen) or in
hypoxia prior to migration. We again observed a significantly
decreased migration of normoxic cells transfected with siRNA
against Snail, relative to the control (Figure 3F). However, motility
of hypoxic cells transfected with siRNA against Snail was in
contrast not significantly decreased due to the knockdown, relative
to control-transfected hypoxic cells (Figure 3F). These results
indicate that the increased migratory ability of MDA-MB-468 cells
observed in hypoxia was independent of Snail, and may instead be
dependent on another factor, or a number of different factors
activated by the hypoxic response.
Nuclear Snail expression is associated with higher grade
and proliferation rate, and is a predictive marker for
tamoxifen response in premenopausal breast cancer
Next, we examined potential associations between Snail expression
and tumour characteristics. The tumour material collected from a
clinical trial of patients randomised to either 2 years of tamoxifen
or no adjuvant treatment after surgery allowed us to investigate the
prognostic effect of Snail expression. Nuclear staining was assessed
as being absent (0) (Figure 4A) or present (1) (Figure 4B). Based
on those criteria 293 (76.3%) and 91 (23.7%) tumours out of the
384 that were assessable, displayed absence or presence of nuclear
Snail staining respectively (Table 2). The majority of tumours
displayed cytoplasmic staining of varying intensity, but we chose
to focus on nuclear staining since Snail is active in the nucleus,
with its functional role as a transcriptional repressor of the E-
cadherin gene. Interestingly, expression of Snail was positively
correlated to tumour grade (P¼0.003) and to expression of the
proliferation marker Ki67 (P¼0.024), implying that nuclear Snail
expression is associated with markers defining a more aggressive
disease in breast cancer (Table 2). However, no associations with
clinicopathological parameters such as tumour size, tumour type
or lymph node status were found. Moreover, nuclear expression of
Snail was inversely correlated to expression of both the ERa
(P¼0.002) and the PR (P¼0.006) (Table 2). No correlation was
observed between Snail expression and HIF-1a, but a positive
correlation to expression of the hypoxia marker CAIX (P¼0.040)
was found, suggesting a possible link between EMT and hypoxia in
breast cancer (Table 2). Notably, cytoplasmic Snail expression was
not associated with any of the variables described. We examined
recurrence-free survival among patients in the untreated control
group according to Snail expression; however, Snail expression
had no prognostic value (Figure 5A). Survival analyses revealed a
trend towards impaired tamoxifen response among patients with
Snail-negative tumours, compared with the those having Snail-
positive tumours (Figure 5B and C). Interestingly, when analysing
patients randomised to tamoxifen treatment vs no adjuvant
treatment, using a multivariate Cox proportional-hazards regres-
sion model for Snail and treatment interaction, a statistically
significant difference between the two subgroups defined by
nuclear Snail expression was observed (P¼0.048) (Table 3). These
results indicate that patients with tumours exhibiting no nuclear
Snail expression are less likely to respond to tamoxifen, as
compared with patients with Snail-positive tumours.
Hypoxic cells of DCIS express nuclear Snail
We continued by investigating the expression of Snail in a model
system of hypoxia in vivo, non-invasive DCIS; DCIS lesions are
often presented with areas of central necrosis where hypoxic
tumour cells are surrounding the necrotic zone. Our aim was to
elucidate whether these hypoxic cells displayed an EMT pheno-
type. Hypoxia-inducible factor-1a staining of full sections of DCIS
confirmed the presence of hypoxia in cell layers adjacent to the
central necrosis. Staining intensity and number of HIF-1a-positive
cells however, varied noticeably between samples and lesions,
suggesting antibody unreliability. The typical HIF-1a expression
pattern that distinguishes DCIS is shown in Figure 6A (Helczynska
et al, 2003). Cytoplasmic Snail expression was present in the
majority of cells, whereas nuclear expression gradually increased
approaching the necrosis, in a number of DCIS samples
(Figure 6B and C). However, E-cadherin and vimentin expression
was not changed in close proximity of the central necrosis (data
not shown). Hence, DCIS did not display EMT-like features, but
the results again confirmed that hypoxia induces Snail expression,
and that this induction does not necessarily affect other EMT
markers.
50 m 50 m
Figure 4 Expression of Snail in primary breast tumours. (A) Tumour core exhibiting absence of Snail expression. (B) A fraction of tumours showed
presence of nuclear Snail expression.
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sDISCUSSION
Epithelial–mesenchymal transition is described as a dynamic and
reversible biological process. As cells from a solid tumour escape
via the circulation and set metastases at new sites due to
conversion of epithelial cells into mesenchymal cells, these cells
are likely to revert back into epithelial cells at the distant site
(Thiery and Sleeman, 2006; Peinado et al, 2007). We have shown in
this study that breast cancer cells can exhibit partially induced
EMT, where Snail induction as a result of hypoxia does not elicit a
motile phenotype even though levels of mesenchymal markers
such as vimentin are increased and E-cadherin levels decrease.
Snail induction resulting from overexpression can conversely
result in a migratory phenotype despite retention of vimentin and
E-cadherin expression levels. Exposure of these breast cancer cell
lines to severe hypoxia induced a shift towards an EMT phenotype,
Table 2 Distribution of Snail staining category according to clinico-
pathological and molecular parameters of invasive breast cancer
Snail nuclear staining
Variable
Negative
(n¼293)
Positive
(n¼91) P
a
Tumour size (mm) 0.901
p20 106 34
420 186 57
Missing cases: 117
Tumour type 0.361
b
Ductal 246 75
Lobular 20 7
Medullary 14 7
Missing cases: 131
Lymph node status 0.893
Negative 80 26
Positive 212 65
Missing cases: 117
NHG 0.003
b
I3 5 6
II 132 30
III 116 52
Missing cases: 129
Ki67 positive (%) 0.024
b
0–1 41 7
2–10 84 24
11–25 67 27
26–50 35 14
51–100 31 15
Missing cases: 155
ERa positive (%) 0.002
o10 76 41
X10 203 50
Missing cases: 130
PR positive (%) 0.006
o10 79 40
X10 194 48
Missing cases: 139
HIF-1a (%) 0.129
b
0–1 176 53
2–10 36 18
11–100 19 8
Missing cases: 190
CAIX 0.040
Negative 219 67
Positive 21 14
Missing cases: 179
Abbreviations: CAIX¼carbonic anhydrase-IX; ER¼oestrogen receptor;
HIF¼hypoxia-inducible factor; NHG¼Nottingham Histologic Grade; PR¼proges-
terone receptor.
aCorrelations were calculated using Fisher’s exact test (two-sided)
unless otherwise specified.
bWilcoxon/Mann–Whitney test (two-sided).
1.0
0.8
0.6
0.4
0.2
0 Snail nuclear
Negative (n=141)
Positive (n=50)
P = 0.505
Snail negative P = 0.512
Snail positive P = 0.174
Control (n=25)
Tamoxifen (n=22)
Control (n=99)
Tamoxifen (n=95)
0 5 10 15 20
Years after randomisation
0 5 10 15 20
Years after randomisation
0 5 10 15 20
Years after randomisation
R
e
c
u
r
r
e
n
c
e
-
f
r
e
e
 
s
u
r
v
i
v
a
l
1.0
0.8
0.6
0.4
0.2
0
R
e
c
u
r
r
e
n
c
e
-
f
r
e
e
 
s
u
r
v
i
v
a
l
1.0
0.8
0.6
0.4
0.2
0
R
e
c
u
r
r
e
n
c
e
-
f
r
e
e
 
s
u
r
v
i
v
a
l
Figure 5 Kaplan–Meier curves showing the effect of Snail on
recurrence-free survival. (A) In the subgroup of untreated control patients
expression of nuclear Snail had no effect on the recurrence rate. (B) For
patients with ERa-positive, Snail-negative tumours no difference in
recurrence-free survival was observed between untreated and treated
patients. (C) A trend towards shorter recurrence-free survival for
untreated ERa-positive, Snail-positive patients as compared with treated
patients, was observed.
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swith elevated levels of Snail protein in all the cell lines, decreased
expression of E-cadherin in MCF-7 cells and increased vimentin
expression in MDA-MB-468 and MDA-MB-231 cells. However,
increased cell migration that has previously been described for
different cell lines as an effect of hypoxic exposure (Imai et al,
2003; Lester et al, 2007), was only observed for MDA-MB-468 cells.
This suggests that these hypoxic breast cancer cells were only
partially pushed towards EMT, with moderate increase in the
E-cadherin repressor Snail. Accordingly, this partial induction is
not sufficient to affect the migratory ability of these cell lines.
Hypoxia is known to affect several factors involved in cell migration
independently of EMT, and consequently the increased migratory
capacity observed for hypoxic MDA-MB-468 cells did not seem to
be an effect of increased Snail protein. The hypoxic response
includes activation of numerous factors associated with cell
motility and cytoskeletal structure (Semenza, 2003), and hence
Snail-dependent migration is only one of several mechanism
suggested to link hypoxia to an enhanced migratory propensity of
tumour cells. The reduced migratory ability observed for MDA-
MB-231 cells exposed to hypoxia may also be due to hypoxic
effects.
Subcellular localisation of Snail has been reported to be
regulated by interaction with GSK-3b, which predominantly
resides in the cytoplasm (Zhou et al, 2004). Zhou et al (2004)
demonstrated in MCF-7 cells that phosphorylation of Snail by
Table 3 Multivariate Cox proportional-hazards model for Snail and
treatment interaction based on ERa-positive breast cancer patients
(n¼325)
a
Recurrence-free survival
Variable HR 95% CI P
Snail nuclear Negative versus positive 0.252
b 0.054–1.184 0.081
Treatment Tamoxifen versus control 0.300
c 0.116–0.776 0.013
Interaction variable
d Tamoxifen Snail nuclear 2.911 1.009–8.395 0.048
Abbreviations: CI¼confidence interval; ER¼oestrogen receptor; HR¼hazards
ratio.
aOther factors included in the multivariate analysis were as follows: age
(continuous), tumour grade (NHG I+II vs III), proliferation (Ki67 0–1, 2–10, 11–25,
26–50, 51–100%), nodal status (negative vs positive) and tumour size (p20 vs
420).
bSnail nuclear HR for the control group.
cTreatment HR for the Snail nuclear-
positive group.
dInteraction variable states whether there is a difference in the
treatment response in relation to Snail nuclear status.
50 m
150 m
Figure 6 Immunohistochemical staining of Snail in DCIS. (A) A schematic representation of a typical HIF-1a staining appearance, with increasing staining
intensity and number of positive cells approaching the central necrosis. (B) Nuclear expression of Snail was gradually increased in proximity to the central
necrosis of DCIS. (C) Magnification ( 20) of the framed area in panel B. Arrows indicate cells with intense nuclear Snail staining.
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in targeting Snail for ubiquitination and the second regulating its
subcellular localisation. A Snail mutant exhibiting mutations in
these phosphorylation motifs was shown to be much more stable
and resided exclusively in the nucleus, suggesting that only Snail
that is unable to interact with and become phosphorylated by GSK-
3b is able to induce EMT in breast cancer cells. Interestingly, when
screening for mutations in the two consensus motifs of Snail, no
mutations could be identified, indicating that the upstream
signalling is the crucial mechanism determining the function of
Snail. Another protein that regulates the activity of Snail is the p21-
activated kinase 1 (Pak1) (Yang et al, 2005). Pak1 phosphorylation
of Snail promotes nuclear accumulation and transcription repres-
sion activity of the E-cadherin gene in breast cancer cells, and
hence induction of EMT (Yang et al, 2005). However, further
studies are required to delineate the mechanism underlying
nuclear, cytoplasmic shuttling and subcellular localisation of Snail.
In the present study we demonstrated that subcellular localisa-
tion of Snail changes over time in breast cancer cell lines exposed
to hypoxia. In MCF-7 cells E-cadherin was hardly detectable after
72h, and expression of nuclear Snail was concurrently elevated,
indicating that at this time point Snail was actively repressing
E-cadherin-gene transcription in this cell line. Similarly, in MDA-
MB-468 and MDA-MB-231 cells nuclear expression levels of Snail
peaked at 96h, around the same time that vimentin expression
levels were markedly elevated in both cell lines. Nuclear expression
of Snail did not increase as prominently in T-47D cells as in the
other cell lines, which might explain the maintained levels of
E-cadherin observed for this cell line. Our results indicate that
hypoxia induces the expression of Snail, and after longer exposure
Snail localises to the nucleus and exerts its EMT-inducing
functions, resulting in downregulation of E-cadherin and upregu-
lation of vimentin levels. The net result differs between cell lines,
suggesting Snail to be more important as a regulator of EMT in
some contexts, and may be inferior to other EMT regulators such
as Slug or Twist in others.
The ‘EMT status’ of a cell line may not affect EMT regulation,
that is, overexpression of Snail can induce a more migratory
phenotype in both low-migratory, epithelial-like cell lines and in
highly migratory, mesenchymal-like cell lines. The fact that Snail
overexpression increased the migratory ability of both MCF-7
and T-47D cells, despite maintenance of E-cadherin expression in
T-47D cells, suggests that E-cadherin expression does not exclude
a migratory behaviour. The highly migratory MDA-MB-231 cells
further increased their migratory capacity when overexpressing
Snail, without exhibiting increased vimentin levels, further
implying that Snail itself can drive migration independently of
an EMT induction. Knocking down Snail resulted in significant
reduction of the migratory capacity of MCF-7, MDA-MB-468 and
MDA-MB-231 cells. The mechanism behind this shift in migration
can again not be explained by regulation of E-cadherin or
vimentin, since expression of neither of the two proteins was
significantly changed by Snail silencing. Hence, another regulator
of cell migration dependent or independent of EMT is possibly
affected by Snail depletion. A plethora of factors play roles in the
induction of EMT and regulating mechanisms generally differ
between cell lines.
A number of studies describing Snail in breast cancer have been
published, and the critical findings differ slightly among them. In
one study Snail immunoreactivity was observed exclusively in the
cytoplasm, contrasting to what is generally observed (Zhou et al,
2004), indicating antibody unreliability in this field of research.
Becker et al (2007) reported 33% of breast cancers as being
positive for nuclear Snail staining, similar to the 31% that we
observed, using the same Snail antibody as in our study. Presence
of nuclear Snail predicted a tumour phenotype displaying a more
poorly differentiated histology and increased proliferation rate in
premenopausal breast cancer, confirming the previously reported
link between EMT and clinical aggressiveness (Cano et al, 2000;
Blanco et al, 2002). Additionally, nuclear Snail protein was
associated with more extensive hypoxia, defined by expression of
the HIF-1a-inducible gene CAIX (Chaudary and Hill, 2006),
implying a link between hypoxia and EMT in primary breast
cancer. However, no correlation between Snail and HIF-1a
expression was observed. Cytoplasmic Snail expression was not
associated with HIF-1a or CAIX, or with any other clinicopatho-
logical variables, suggesting that expression of nuclear Snail plays
the main role in determining the extent of clinical aggressiveness
in breast cancer. A negative correlation between nuclear Snail and
presence of ERa was observed, and this inverse relationship has
previously been reported with a number of breast tumour
materials analysed by microarray (Dhasarathy et al, 2007).
Moreover, Snail has been reported to directly repress ERa-gene
transcription in MCF-7 cells by binding to the promoter region
(Dhasarathy et al, 2007). The ER–MTA3–E-cadherin pathway has
emerged as a novel pathway in the regulation of ER signalling, and
allelic alterations in these genes have been reported to be
associated with both tumour-promoting and antitumour mechan-
isms (Cheng et al, 2001; Fearon, 2003). Furthermore, Snail
suppresses the expression of the oestrogen-converting enzyme
aromatase (Kumar, 2003), resulting in reduced levels of peripheral
oestrogen converted from adipose tissue, which should be
protective against breast cancer. The molecular function of Snail
in breast epithelium is intricate and is further complicated by
interaction with its downstream targets, such as the ER. Moreover,
aetiological factors such as, for example, age at first full-term
pregnancy, affects the importance of Snail as a susceptibility
marker, and single-nucleotide polymorphism (SNP) of Snail has
been shown to be of importance for the oestrogen-related risk
factor in relation to breast cancer risk (Yu et al, 2006). In one study
it was demonstrated that 17b-estradiol (E2) treatment, in an ERa
mediated manner, resulted in increased metastatic potential,
morphological changes characteristic of EMT and increased
transcriptional activity of the Snail and Slug genes, accompanied
by decreased levels of E-cadherin in an ovarian cancer cell line
(Park et al, 2008). Silencing of either Snail or Slug caused reversion
of the mesenchymal-like phenotype, and in addition treatment
with the oestrogen antagonist ICI was shown to overcome the
inhibitory effect of E2 on E-cadherin transcription, suggesting a
crucial role for oestrogen and its receptor in EMT-dependent
tumour progression. Interestingly, in the same study it was also
demonstrated that presence of ERb had an opposing effect on ERa,
in the context of EMT regulation, inhibiting the ERa-induced EMT
(Park et al, 2008). These findings may explain the mechanism by
which ER status regulates invasion and metastasis in breast cancer.
Nevertheless, the effect of oestrogen and the role of ER in the
context of Snail and EMT regulation remain elusive. The fact that
patients with Snail-negative tumours exhibited impaired tamoxifen
response, as compared with treated patients with Snail-positive
tumours in our study, is intriguing, but the underlying mechanism
is yet to be elucidated. Speculatively, Snail may affect the function
of ERa in a way that potentiates the effect of the ER antagonist
tamoxifen. In tumours with nuclear Snail expression, tamoxifen
might exert its effect by inhibiting the function of Snail, as
described previously for the antagonist ICI. This in turn may lead
to a less invasive tumour phenotype, since EMT is reverted. In
Snail-negative tumours tamoxifen would not be able to exert the
same mechanistic effect, resulting in an abolished response.
Expression of ERb may also influence the mechanism that renders
patients with Snail-negative tumours non-responsive to tamoxifen.
Evidently, further studies including large randomised clinical
cohorts are needed to investigate the role of Snail as a treatment
predictive marker in breast cancer.
Moreover, in DCIS cells adjacent to the central necrosis
exhibited nuclear Snail, further confirming an association between
hypoxia and EMT. However, expression of E-cadherin and
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svimentin was not changed in areas with nuclear Snail staining,
suggesting that Snail can be upregulated without affecting the
expression of other EMT markers in vivo, as was also demon-
strated in our breast cancer cell lines.
Our present study provides further evidence of the critical role
of Snail in tumorigenic behaviour of breast cancer cell lines, and its
association with clinicopathological parameters defining a more
aggressive tumour phenotype. We demonstrate that breast cancer
cells can enter a hybrid state of EMT, which is distinguished by
partial mesenchymal conversion, where some hallmarks of EMT
are present and others absent. Loss of E-cadherin expression is
a well-established definition of invasiveness (Mayer et al, 1993;
Oka et al, 1993). It has, however, been debated whether this
definition is reliable or not (Christiansen and Rajasekaran, 2006).
The expression of E-cadherin was reported in one study to be
present in the majority of invasive breast carcinomas examined
(Hashizume et al, 1996). Furthermore, node-negative and node-
positive tumours exhibited similar E-cadherin expression and no
correlation between E-cadherin expression and metastatic status
was observed. A number of additional reports show similar results
regarding E-cadherin expression and tumour aggressiveness, imply-
ing that invasion is not necessarily dependent on a complete
transition to a mesenchymal phenotype (Parker et al, 2001; Kovacs
et al, 2003). Barrallo-Gimeno and co-workers argued that the
primary function of Snail is to enhance cell movement, rather than
to induce EMT (Barrallo-Gimeno and Nieto, 2005). In addition,
Lou et al (2008) reported that the metastatic ability was not linked
to the EMT status. A cell line with expression of vimentin and lack
of E-cadherin expression was unable to metastasise, whereas
another cell line exhibiting epithelial characteristics was capable of
metastasising. Accordingly, the question if a primary tumour will
metastasise or not may not be determined by the EMT phenotype
of the tumour cells. The expression of Snail itself may hold more
information about a tumour’s invasive capacity and ability to
metastasise than the actual EMT status.
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